Gurnet Partner closes take-private acquisition of Innocoll

Gurnet Point has acquired Innocoll for about $209 million in a take-private deal. As a result of the transaction, Innocoll will no longer trade on the NASDAQ. Innocoll is a pharmaceutical and medical device company.

24 July 2017•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles